BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• 

  Government

  Tariffs Would Impede Access to Affordable Drugs, Industry Warns

  Donald Trump’s proposed tariffs on the EU would increase manufacturing costs for pharma companies and would stall medical innovation, according to the results of a recent survey by the Biotechnology Innovation Organization.

  March 26, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Defence Announces US Molecular and Antibody Research Expert Dr. Elias Theodorou Joins Defence’s Management Team as Chief Operating Officer

  March 26, 2025

   · 

  4 min read
• Press Releases

  BioMark Secures Financing for Initial Tranche to Advance Early-Detection Oncology Testing Platform

  March 26, 2025

   · 

  6 min read
• Press Releases

  Exelixis Announces U.S. FDA Approval of CABOMETYX® (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors

  March 26, 2025

   · 

  19 min read
• Press Releases

  Omeros Corporation to Announce Fourth Quarter and Year-end Financial Results on March 31, 2025

  March 26, 2025

   · 

  2 min read
• Press Releases

  Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025

  March 26, 2025

   · 

  2 min read
• 

  Duchenne muscular dystrophy

  Wave’s Duchenne Exon-Skipper Reverses Muscle Damage in Mid-Stage Trial

  WVE-N531, an oligonucleotide, elicited significant functional benefit and reversal of muscle damage in the Phase II FORWARD-53 trial. Wave plans to file for accelerated approval of the candidate in 2026.

  March 26, 2025

   · 

  3 min read

   · 

  Heather McKenzie
• Press Releases

  Juncell Therapeutics to Present Preclinical Data on Innovative Pretreatment Regimen of TIL Therapy at AACR Annual Meeting 2025

  March 26, 2025

   · 

  2 min read
• 

  China

  Bayer Jumps on Chinese Partnership Train with Oncology Deal

  The German conglomerate announced a licensing agreement with Puhe BioPharma for a PRMT5 inhibitor used in a variety of cancers. Financial details of the deal were not disclosed.

  March 26, 2025

   · 

  1 min read

   · 

  Dan Samorodnitsky
• Press Releases

  SOTIO to Present Preclinical Data on Lead Antibody-Drug Conjugates, SOT106 and SOT109, at 2025 AACR Annual Meeting

  March 26, 2025

   · 

  2 min read